Ketamine modulates a norepinephrine-astroglial circuit to persistently suppress futility-induced passivity
Authors:
- Marc DuqueMDMarc Duque
- Alex B. ChenACAlex B. Chen
- Eric HsuEHEric Hsu
- Sujatha NarayanSNSujatha Narayan
- Altyn RymbekARAltyn Rymbek
- Shahinoor BegumSBShahinoor Begum
- Gesine SaherGSGesine Saher
- Adam Ezra CohenACAdam Ezra Cohen
- David E. OlsonDODavid E. Olson
- David A ProberDPDavid A Prober
- Dwight E BerglesDBDwight E Bergles
Preprint
Abstract
Rapid-acting antidepressants like ketamine hold promise to change the approach to treatment of major depressive disorder (MDD),1–3 but their cellular and molecular targets remain unclear. Passivity induced by behavioral futility underlies learned helplessness, a process that becomes maladaptive in MDD.4, 5 Antidepressants inhibit futility-induced passivity (FIP) in rodent models such as the forced swimming6 or tail suspension7 tasks, but these models lack the throughput and accessibility for screening compounds and investigating their effects on the brain in vivo. Therefore, we adapted a recently discovered FIP behavior8 in the small and optically accessible larval zebrafish to create a scalable behavioral assay for antidepressant action. We found that rapid-acting antidepressants with diverse pharmacological targets demonstrated a suppression of FIP conserved between fish and rodents. While fast-acting antidepressants are thought to primarily target neurons,2, 9, 10 using brain-wide imaging in vivo we found, surprisingly, that ketamine, but not psychedelics or typical antidepressants, drove cytosolic calcium elevation in astroglia lasting many minutes. Blocking neural activity did not prevent ketamine’s effects on FIP or astroglial calcium, suggesting an astroglia-autonomous mechanism of ketamine’s action. Chemogenetic and optogenetic perturbations of astroglia reveal that the aftereffects of calcium elevation are sufficient to suppress FIP by inhibiting astroglial integration of futile swimming. In sum, our work provides evidence that ketamine exerts its antidepressant effects by inhibiting an astroglial population that integrates futility and changes behavioral state. Astroglia play central roles in modulating circuit dynamics,11 and our work argues that targeting astroglial signaling may be a fruitful strategy for designing new rapid-acting antidepressants.Keywords
This publication has 54 references indexed in Scilit:
- NMDA receptor blockade at rest triggers rapid behavioural antidepressant responsesNature, 2011
- mTOR-Dependent Synapse Formation Underlies the Rapid Antidepressant Effects of NMDA AntagonistsScience, 2010
- Zebrafish Behavioral Profiling Links Drugs to Biological Targets and Rest/Wake RegulationScience, 2010
- Efficient transposition of the Tol2 transposable element from a single-copy donor in zebrafishProceedings of the National Academy of Sciences, 2008
- Transparent Adult Zebrafish as a Tool for In Vivo Transplantation AnalysisCell Stem Cell, 2008
- 1-Aminomethylbenzocycloalkanes: Conformationally Restricted Hallucinogenic Phenethylamine Analogues as Functionally Selective 5-HT2AReceptor AgonistsJournal of Medicinal Chemistry, 2006
- Chemical suppression of a genetic mutation in a zebrafish model of aortic coarctationNature Biotechnology, 2004
- Functional antagonists at the NMDA receptor complex exhibit antidepressant actionsEuropean Journal of Pharmacology, 1990
- Failure to escape traumatic shock.Journal of Experimental Psychology, 1967
- Effects of inescapable shock upon subsequent escape and avoidance responding.Journal of Comparative and Physiological Psychology, 1967